The recent passing of actor James Van Der Beek has drawn attention to a worrying trend: colorectal cancer is increasingly affecting younger people. While the overall cancer death rates for individuals under 50 have dropped by 44% since 1990, colorectal cancer is now the top cause of cancer death in this age group, according to the American Cancer Society.
Colorectal cancer, which develops in the colon or rectum, is often preceded by the growth of polyps. These polyps can turn cancerous over time. Van Karlyle Morris, a colorectal cancer expert at MD Anderson Cancer Center, predicts that this trend of rising cases among young adults is likely to continue.
As a result, health guidelines were updated in 2021, lowering the recommended screening age from 50 to 45. This change was based on new research highlighting rising incidence rates in younger populations. Strikingly, only about 20% of people aged 44-49 are current with their screenings, despite being eligible.
Interestingly, while most colorectal cancer cases are still found in older adults, rates among those in their 20s and 30s have risen sharply. Experts like Dr. Andrew Chan from Mass General Brigham suggest that the actual risk for 40 to 44-year-olds is about 21 per 100,000, which over doubles by age 45.
The increase in colorectal cancer cases among younger people raises questions about current screening practices. Some health professionals are advocating for even earlier screenings for those with a family history of colorectal issues. Rebecca Siegel from the American Cancer Society emphasizes the importance of communication about family health history.
Recognizing early symptoms is crucial. In Van Der Beek’s case, he first noticed changes in his bowel movements at 46, mistakenly attributing them to coffee. Symptoms can vary and include abdominal pain, rectal bleeding, and ongoing diarrhea.
Recent studies also highlight some promising developments in early detection through noninvasive tests like Cologuard and blood tests. However, these tests are often not as effective as a colonoscopy in detecting all cases, especially precancerous polyps.
The cost of a colonoscopy without insurance can be daunting, ranging from $1,250 to over $4,000. Insurance coverage for these screenings typically begins at age 45 unless specific risk factors necessitate earlier testing.
Finally, experts suggest that lifestyle changes can significantly impact colorectal cancer risk. Rising rates of obesity and sedentary lifestyles are potential contributors to the rising incidence. Both diet and exercise play a role in prevention, offering benefits beyond just the importance of screening.
In light of these developments and statistics pointing toward an increase in colorectal cancer among younger individuals, ongoing discussion about screening guidelines and lifestyle changes is essential for public health.
Source link
